Tag: Patients
Search News
NHS Innovation Accelerator
5th March 2019
Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts Health NHS Trust, was announced today as one of 13 Fellows to join the NHS […]
Read more
Treatment for advanced kidney cancer
13th February 2019
A combination therapy has shown powerful anticancer responses in patients with a type of advanced kidney cancer in a new international phase III clinical trial (KEYNOTE-426). Treatment with the combination therapy resulted in significant increases in overall survival when compared with the current standard of care, and the findings will help to provide a vital new treatment option for patients with this disease.
Read more
Tackling tumour scar tissue could be key to treating pancreatic cancer
11th February 2019
The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.
Read more
Genomics project reaches goal of 100,000 genomes sequenced from NHS patients
6th December 2018
UK Health Secretary Matt Hancock announced yesterday that a project involving Queen Mary researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients.
Read more
Tackling the deadliest cancer type
30th November 2018
November is Lung Cancer Awareness Month. Lung cancer is one of the main cancer types on which research is focused here at the Barts CRUK Centre.
Read more
New phase III clinical trial using combination therapy extends survival in triple-negative breast cancer
22nd October 2018
Research provides new hope for people with an aggressive type of breast cancer.
Read more